Sparse Uterine Closure in Cesarean Section
Sparse Uterine Closure in Caesarean Section: Short and Mid Term Results
1 other identifier
interventional
100
1 country
1
Brief Summary
The existence and the characteristics of a wedge- shaped defect in the uterine incision scar were demonstrated by radiologic, ultrasonographic, endoscopic and histologic methods by various authors. Cesarean scar defect is a deficient uterine scar or scar dehiscence following a cesarean section involving myometrial discontinuity at the site of a previous cesarean section scar. Cesarean scar defects may be associated with many clinical problems such as ectopicpregnancy at the cesarean section scar, rupture of the uterus during a subsequent pregnancy, dysmenorrhea and abnormal uterine bleeding during the non-pregnant state. These complications are likely to be associated with poor uterine scar healing following cesarean sections. Methods concerning closure of the uterine incision need to be considered with regards to benefit and potential harm in order to offer the best available surgical care to women undergoing cesarean section. Sur-gical suturing technique and mechanical tension affecting the surgical wound are the most important factors related to the incisional integrity. For this reason, investigators designed this prospective clinical study to analyze the effects of two different uterine suturing techniques. their aim was to compare the sparse closure of the uterine incision to classical one layer closure regarding short , mid and long term results. In deed, they compared :
- duration of surgery and calculated blood loss during surgery as short term results - incidence of postoperative defective healing of the uterine incision , thickness of the ultrasound imaged uterine scar as mid-term results .
- Incomplete uterine rupture, morbidly placental adhesion during subsequent pregnancy of these patients as long-term results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 23, 2019
CompletedFirst Posted
Study publicly available on registry
April 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2020
CompletedJanuary 10, 2020
January 1, 2020
11 months
April 23, 2019
January 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
uterine scar quality
ultrasound visualization of a defect on the internal wall of the uterine scar (niche)
6 mounth after surgery
Secondary Outcomes (3)
uterine scar thickness
6 mounth after surgery
duration of surgery
during the caesarean section
calculated blood loss
before and 24 hours after surgery
Study Arms (2)
sparse uterine suture
EXPERIMENTALwomen who had a french ambulatory casarean section including a sparse uterine closure
one layer uterine closure
ACTIVE COMPARATORwomen who had a misgav ladach caesarean section section, including a one layer classical uterine closure
Interventions
The slowly absorbed Vicryl 1 suture with a large round needle is introduced intramyometrially right above the endometrium. The suture starts in one corner and proceeds along the lower then the upper edge returning back to the incision point. Subserous layer is closed upon using the same thread in order to cover the purse suture and to complete the haemostasis while increasing the wound thickness.
one layer classical continious uterine closure using slowly absorbed Vicryl 1
Eligibility Criteria
You may qualify if:
- singleton pregnancy
- Cicatricial uterus with contraindication to vaginal delivery (uterus bi or multi-cicatricial, corporal uterine scar, intra-mural myomectomy, dystocic presentation)
- Fetal macrosomia with a weight greater than 4Kg
- Placenta previa
You may not qualify if:
- Patients who refuse to participate in the study
- prenatally diagnosed fetal pathology (intrauterine growth restriction, malformation, genetics disorders)
- adherent placenta, an adnexal mass or a myoma at the lower uterine segment
- Cesarean section in a context of medical or obstetrical emergency
- Caesarean section with a high risk of bleeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaouther Dimassi
Tunis, Sidi Daoued La Marsa, 2045, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor in obstetrics and gynecology
Study Record Dates
First Submitted
April 23, 2019
First Posted
April 29, 2019
Study Start
February 1, 2019
Primary Completion
December 30, 2019
Study Completion
January 2, 2020
Last Updated
January 10, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share